Hyderabad, 502325,
India
Bio-Pharma Laboratories Technographics
Bio-Pharma Laboratories Technographics, Software Purchases, AI and Digital Transformation Initiatives
Discover the latest software purchases and digital transformation initiatives being undertaken by Bio-Pharma Laboratories and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 50 Bio-Pharma Laboratories employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.
During our research, we have identified that Bio-Pharma Laboratories has purchased the following applications: LabWare LIMS for Laboratory Management in 2024 and the related IT decision-makers and key stakeholders.
Our database provides customer insight and contextual information on which enterprise applications and software systems Bio-Pharma Laboratories is running and its propensity to invest more and deepen its relationship with LabWare or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.
We have been analyzing Bio-Pharma Laboratories revenues, which have grown to $10.0 million in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for Bio-Pharma Laboratories intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.
Bio-Pharma Laboratories Tech Stack and Enterprise Applications
Bio-Pharma Laboratories ERP Services and Operations
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| LabWare | Legacy | LabWare LIMS | Laboratory Management | ERP Services and Operations | n/a | 2024 | 2024 |
In 2024, Bio-Pharma Laboratories implemented LabWare LIMS for Laboratory Management to establish cross-functional connectivity between R&D, Quality Control, manufacturing, and regulatory functions. The initiative targeted a compact laboratory organization of about 50 employees, prioritizing secure information sharing and collaboration to reduce silos and accelerate handoffs between teams.
Configuration emphasized core Laboratory Management capabilities, including sample lifecycle and inventory management, workflow orchestration for test scheduling and approvals, electronic data capture with audit trails, and role-based access controls to manage information flow. LabWare LIMS was positioned as the laboratory nerve center to simplify complex processes and encourage team-wide cooperation across experiment execution and test reporting.
The implementation included integration with electronic laboratory notebook solutions and mechanisms for timely notifications between R&D and QC when discoveries or production issues occur, and for propagating regulatory updates across departments. Connectivity was delivered using standard integration patterns such as API-based interfaces and secure data exchange to preserve traceability and data integrity across systems.
Governance changes focused on standardized workflows, defined QC approval gates, and strengthened documentation controls to ensure repeatable compliance and clear handoffs between functions. Explicit outcomes referenced in project materials include a reduction in error rates by at least 10% and an increase in completed projects by approximately 10% when collaboration is improved, outcomes that align with LabWare LIMS goals of nipping mistakes in the bud and enabling a smoother transition from research to market-ready product.
|
IT Decision Makers and Key Stakeholders at Bio-Pharma Laboratories
| First Name | Last Name | Title | Function | Department | Phone | |
|---|---|---|---|---|---|---|
| No data found | ||||||
Apps Being Evaluated by Bio-Pharma Laboratories Executives
| Date | Company | Status | Vendor | Product | Category | Market |
|---|---|---|---|---|---|---|
| No data found | ||||||